Clinical trial
An Observational Study of the Use and Safety of Raptiva During Pregnancy…
NCT00097240 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00097240 |
|---|---|
| Title | An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW) |
| Official title | The Raptiva Pregnancy Registry: An Observational Study of the Use and Safety of Raptiva (Efalizumab) During Pregnancy |
| Acronym | FOLLOW |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Psoriasis, Pregnancy |
| Enrollment | 18 |
| Start date | Jan 1, 2005 |
| Completion | Sep 1, 2009 |
| First posted | Nov 22, 2004 |
| Last update posted | Aug 4, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: